Leave it to Queen B to kill it on the red carpet. This black gown is classy, glamorous, and sexy… everything we love!
The Grammy awards, a.k.a. the biggest night in music, brings out the industry's hottest stars.And with Beyonce, Rihanna, Katy Perry, Ariana Grande, and Madonna attending the 2015 Grammy red carpet, we were treated to a variety of fabulous, unique, and not-so-great ensembles.
So who dominated the red carpet, and who failed to impress?
Jennifer Aniston, Kate Hudson and Jennifer Lawrence are leading the silicone-free trend proving that natural silhouette is in.
A plunging neckline closing three inches below a woman's cleavage is the new super-low-cut trend being worn by the biggest names on the red carpet.
At one time, pair of silicone breasts were the ultimate accessory when it came to pulling off the look just look to Katie Price and Pamela Anderson for proof. But fast forward a few years and it seems the silicone trend is officially out.
The likes of Jennifer Lawrence, Jennifer Aniston, Kate Hudson, who was rumoured, but never confirmed to have had a small enhancement from an AA to a B back in 2010, and Sienna Miller have been championing a more natural silhouette as they take to the red carpet in their daring dresses and clinical stats back it up.
According to a study presented at the 2014 American Society for Dermatologic Study Annual Meeting, patients receiving continuous Botox treatment over the course of several years perceived themselves to look younger than their actual age.
Alistair Carruthers, Fellow of the Royal College of Physicians of Canada (FRCPC) presented the results of the study, which assessed 194 patients, aged 18 and above, with at least five years history of continuous treatment.
Carruthers and his team reviewed patient records of Botox treatments from 1999 to 2012, evaluating facial areas treated, dosage per area, number of treatments performed, any accompanying aesthetic treatments and any adverse events associated with the Botox treatment.
The mean age at first injection was 46.3 years, and data was collected from 5,112 treatment sessions with an average of two or more treatments annually, over a mean of 9.1 years.
The researchers found that the longer patients were injected, the younger they perceived themselves to be. They also found that although dosing for glabellar lines and crows' feet remained stable over the period covered, dosing for forehead lines had decreased since 1999.
